Latest Close
$4.80
News
ACRS
Aclaris Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to ACRS.
1y Change
$3.58 (+293.44%)
Market Cap
$670,385,664.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
GlobeNewswire • May 8, 2026
Read articleAclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates
Zacks • May 7, 2026
Read articleAclaris: Q1 Earnings Snapshot
Associated Press • May 7, 2026
Read articleAclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update
GlobeNewswire • May 7, 2026
Read articleRigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates
Zacks • May 5, 2026
Read articleCompanies Like Aclaris Therapeutics (NASDAQ:ACRS) Are In A Position To Invest In Growth
Simply Wall St. • May 4, 2026
Read article